ArticleItalian journal of pediatrics2025
Calcified necrotizing funisitis and its association with adverse neonatal outcomes: a case-control study.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundNecrotizing funisitis (NF) is a rare but severe type of umbilical inflammation. Whether NF can affect the outcomes of newborns is still controversal. The aim of this article is to determine the association of calcified necrotizing funisitis with adverse neonatal outcomes.
methodThis retrospective study included newborns who had undergone pathological examination between July 2020 and July 2024. Twenty-one neonates who were delivered at Jinan Maternity and Child Health Hospital with pathological results of calcified NF were retrospectively selected as the study group. Concurrently, 42 neonates admitted during the same period without a pathological finding of calcified NF were chosen as the control group. These control subjects were matched to the study group at a ratio of 1:2 according to gestational age. The outcome indicators of the neonates in both groups were comparable.
resultsAll infants in both groups were preterm (gestational age < 37 weeks), with the NF group and non-NF group having a gestational age of 30+ 1±2+ 4 weeks. Compared with the control group, the observation group exhibited statistically significant differences in several maternal and neonatal outcomes. Specifically, the observation group had a higher rate of spontaneous vaginal delivery (P = 0.023), prolonged rupture of membranes (P < 0.001), and increased neonatal levels of white blood cells (P < 0.001), C-reactive protein (P < 0.001), and neutrophil proportion (P = 0.002). Conversely, the incidence of respiratory distress syndrome (P = 0.031), retinopathy of prematurity (P = 0.018), and duration of invasive ventilation use (P = 0.032) were significantly lower in the observation group, with all differences being statistically significant (P < 0.05). Ureaplasma urealyticum infection refers to the transmission of the organism from the mother to the neonate prior to or during delivery. Among the 21 patients in the case group, 14 (66.70%) were identified as positive for UU infection, whereas 4 (9.50%) in the control group tested positive. Such differences were statistically significant (P < 0.001).
conclusionIn neonates with placental pathology showing NF, there are significant increases in white blood cell count, C-reactive protein levels, and neutrophil proportion. However, these neonates exhibit a shorter duration of invasive mechanical ventilation, along with reduced incidences of respiratory distress syndrome and retinopathy of prematurity. Ureaplasma urealyticum infection has been identified as a risk factor for calcified neonatal fever.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.